251 related items for PubMed ID: 23283289
1. Advances in the treatment of Kawasaki disease.
Dominguez SR, Anderson MS.
Curr Opin Pediatr; 2013 Feb; 25(1):103-9. PubMed ID: 23283289
[Abstract] [Full Text] [Related]
2. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997
[Abstract] [Full Text] [Related]
3. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.
Pediatrics; 2004 Dec 17; 114(6):e689-93. PubMed ID: 15545617
[Abstract] [Full Text] [Related]
4. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
Arch Dis Child; 2008 Feb 17; 93(2):142-6. PubMed ID: 17962370
[Abstract] [Full Text] [Related]
5. Infliximab treatment for refractory Kawasaki syndrome.
Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME.
J Pediatr; 2005 May 17; 146(5):662-7. PubMed ID: 15870671
[Abstract] [Full Text] [Related]
6. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
Wooditch AC, Aronoff SC.
Pediatrics; 2005 Oct 17; 116(4):989-95. PubMed ID: 16199713
[Abstract] [Full Text] [Related]
7. Kawasaki disease: a comprehensive review of treatment options.
Patel RM, Shulman ST.
J Clin Pharm Ther; 2015 Dec 17; 40(6):620-5. PubMed ID: 26547265
[Abstract] [Full Text] [Related]
8. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.
Dale RC, Saleem MA, Daw S, Dillon MJ.
J Pediatr; 2000 Nov 17; 137(5):723-6. PubMed ID: 11060542
[Abstract] [Full Text] [Related]
9. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
Miyata K, Kaneko T, Morikawa Y, Sakakibara H, Matsushima T, Misawa M, Takahashi T, Nakazawa M, Tamame T, Tsuchihashi T, Yamashita Y, Obonai T, Chiga M, Hori N, Komiyama O, Yamagishi H, Miura M, Post RAISE group.
Lancet Child Adolesc Health; 2018 Dec 17; 2(12):855-862. PubMed ID: 30337183
[Abstract] [Full Text] [Related]
10. [Anti TNF-α (infliximab) treatment for intravenous immunoglobulin (IVIG) resistance patients with acute Kawasaki disease the effects of anticytokine therapy].
Saji T, Takatsuki S, Kobayashi T.
Nihon Rinsho; 2014 Sep 17; 72(9):1641-9. PubMed ID: 25518416
[Abstract] [Full Text] [Related]
11. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.
Mori M, Imagawa T, Hara R, Kikuchi M, Hara T, Nozawa T, Miyamae T, Yokota S.
J Rheumatol; 2012 Apr 17; 39(4):864-7. PubMed ID: 22337241
[Abstract] [Full Text] [Related]
12. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Pediatrics; 2004 Dec 17; 114(6):1708-33. PubMed ID: 15574639
[Abstract] [Full Text] [Related]
13. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA, Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association, American Academy of Pediatrics.
Circulation; 2004 Oct 26; 110(17):2747-71. PubMed ID: 15505111
[Abstract] [Full Text] [Related]
14. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
PLoS One; 2015 Oct 26; 10(12):e0144603. PubMed ID: 26658843
[Abstract] [Full Text] [Related]
15. Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis.
Chen S, Dong Y, Yin Y, Krucoff MW.
Heart; 2013 Jan 26; 99(2):76-82. PubMed ID: 22869678
[Abstract] [Full Text] [Related]
16. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial.
Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, Jain SS, Michalik DE, Sharma K, Truong DT, Wood JB, Kim KK, Jain S, KIDCARE Multicenter Study Group.
Lancet Child Adolesc Health; 2021 Dec 26; 5(12):852-861. PubMed ID: 34715057
[Abstract] [Full Text] [Related]
17. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease.
Kobayashi T, Kobayashi T, Morikawa A, Ikeda K, Seki M, Shimoyama S, Ishii Y, Suzuki T, Nakajima K, Sakamoto N, Arakawa H.
J Pediatr; 2013 Aug 26; 163(2):521-6. PubMed ID: 23485027
[Abstract] [Full Text] [Related]
18. Revisiting the role of steroids and aspirin in the management of acute Kawasaki disease.
Dhanrajani A, Yeung RSM.
Curr Opin Rheumatol; 2017 Sep 26; 29(5):547-552. PubMed ID: 28661936
[Abstract] [Full Text] [Related]
19. Intravenous Immunoglobulin for the Treatment of Kawasaki Disease.
Shulman ST.
Pediatr Ann; 2017 Jan 01; 46(1):e25-e28. PubMed ID: 28079915
[Abstract] [Full Text] [Related]
20. [Efficacy and safety of glucocorticoids in addition to intravenous immunoglobulin in the initial treatment of Kawasaki disease: a meta-analysis of randomized trials].
Hu JW, Zhou ZS, Yang L, Zheng CN, Wang KD.
Zhonghua Yi Xue Za Zhi; 2011 May 17; 91(18):1259-64. PubMed ID: 21756798
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
